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Byr2 protein kinase, a homolog of mammalian mitogen-activated protein kinase/extracellular signal-regu-
lated kinase kinase (MEKK) and Saccharomyces cerevisiae STE11, is required for pheromone-induced sexual
differentiation in the fission yeast Schizosaccharomyces pombe. Byr2 functions downstream of Ste4, Ras1, and
the membrane-associated receptor-coupled heterotrimeric G-protein a subunit, Gpa1. Byr2 has a distinctive
N-terminal kinase regulatory domain and a characteristic C-terminal kinase catalytic domain. Ste4 and Ras1
interact with the regulatory domain of Byr2 directly. Here, we define the domains of Byr2 that bind Ste4 and
Ras1 and show that the Byr2 regulatory domain binds to the catalytic domain in the two-hybrid system. Using
Byr2 mutants, we demonstrate that these direct physical interactions are all required for proper signaling. In
particular, the physical association between Byr2 regulatory and catalytic domains appears to result in
autoinhibition, the loss of which results in kinase activation. Furthermore, we provide evidence that Shk1, the
S. pombe homolog of the STE20 protein kinase, can directly antagonize the Byr2 intramolecular interaction,
possibly by phosphorylating Byr2.
The mitogen-activated protein kinase (MAPK) module is an
important and highly conserved element in eukaryotes. Com-
posed of a series of protein kinases that can phosphorylate one
another sequentially, the module is thought to transmit signals
from the point of origin, typically the cell membrane, to the
nucleus (2, 4, 5, 11, 15, 31). A basic MAPK module consists of
three kinases: a MAPK, a MAPK/extracellular signal-regulat-
ed kinase (ERK) kinase (MEK), and a MEK kinase (MEKK).
In responding to plasma membrane-originating signals, MEKK
phosphorylates and activates MEK, which in turn phosphory-
lates and activates MAPK/ERK (27). As a result, targets in-
cluding transcription factors are phosphorylated (8, 10). This
module has been found in various signaling pathways ranging
from the pheromone-induced sexual differentiation in yeast to
the induction of cell proliferation and differentiation in mam-
malian cells. In the budding yeast Saccharomyces cerevisiae, the
MAPK module controlling pheromone-induced sexual differ-
entiation consists of STE11, STE7, and the pair of FUS3 and
KSS1 kinases. In the fission yeast Schizosaccharomyces pombe,
the triad composed of Byr2, Byr1, and Spk1 is similarly in-
volved in sexual differentiation (31). Mammalian cells have at
least two prominent kinase cascades: MEKK, JNKK, and JNK
(29, 42) and RAF, MEK, and MAPK (7, 18, 22). RAF is itself
a target for Ras proteins (37, 39) and may be under very
complex regulation.
Sexual differentiation in S. pombe is under the influence of
both sex pheromones and starvation, and Byr2, like RAF,
appears to be a target for regulation by Ras (38). Given the
amenability of S. pombe for genetic analysis, Byr2 is thus an
excellent candidate for the study of complex regulation. In
addition to being regulated by Ras1, Byr2 also appears to be
regulated by Ste4 and Gpa1. Ste4 has a leucine zipper capable
of homotypic interaction and another domain capable of bind-
ing Byr2 (3). Gpa1 is the a subunit of the membrane-associ-
ated pheromone receptor-coupled heterotrimeric G-protein
(32). Gpa1 is thought to be activated upon the binding of
pheromones to their receptors. Ras1 and Gpa1 cooperate in
regulating the sexual differentiation pathway (41), and Ste4
and Ras1 appear to activate Byr2 at least partially indepen-
dently (3), but the relationship between Ste4 and Gpa1 has not
been clarified.
We have been utilizing the two-hybrid system of Fields and
Song to probe the mechanisms for Byr2 activation (13). Ras1
has been found to bind Byr2 in the two-hybrid system (37).
Masuda et al. have demonstrated this interaction in vitro (28).
Ste4, isolated as a Byr2-binding protein from a two-hybrid
interaction screen, has also been shown to bind Byr2 in vitro
(3). A two-hybrid bridging experiment has demonstrated that
the regulatory domain of Byr2 can bind Ste4 and Ras1 simul-
taneously (3). We have now discovered that the Byr2 kinase
catalytic domain can also bind to the regulatory domain of
Byr2. We have determined the minimum binding domain for
each of these interactions by characterizing the binding profile
of a series of Byr2 deletion mutants, and point mutants that are
defective only in the ability to bind either Ste4, Ras1, or the
kinase catalytic domain have been isolated. Analysis of these
mutants shows that direct interactions between the Byr2 reg-
ulatory domain and Ste4 and Ras1 are required for the proper
activity of Byr2. The interaction between the Byr2 regulatory
domain and the kinase catalytic domain appears to be autoin-
hibitory, since the loss of this interaction results in enhanced
activity. With the two-hybrid system, we are able to show that
Shk1, the S. pombe homolog of S. cerevisiae STE20, a kinase
thought to be upstream of the sexual differentiation MAPK
module in that organism (24), can antagonize the interaction
of the regulatory and catalytic domains, possibly by phosphor-
ylating Byr2, with a resultant activation of the kinase. From
these data we have proposed a model for the distributive reg-
ulation of Byr2 by Ras1, Ste4, and Shk1.
MATERIALS AND METHODS
Yeast, media, and genetic manipulations. The genotypes of all S. cerevisiae and
S. pombe strains used in this study are listed in Table 1. S. cerevisiae HF7C, L40,
and YCJ4 were used as reporter strains for two-hybrid interaction experiments.
HF7C is a GAL4-based two-hybrid reporter strain, and L40 is lexA based. Con-
structed and kindly provided by Tim Durfee and Carla Inouye at the University
of California, Berkeley, YCJ4 is a dual reporter strain that has both GAL4-based
* Corresponding author. Phone: (516) 367-8376. Fax: (516) 367-
8381.
† Present address: Department of Biology, California Institute of
Technology, Pasadena, CA 91125.
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and lexA-based two-hybrid reporter constructs (19). All S. pombe strains used in
this study were derived from the wild-type SP870 strain, and they have been used
in our previous studies.
S. cerevisiae cultures were grown in YPD (2% peptone, 1% yeast extract, 2%
glucose) or in dropout (DO) synthetic minimal medium (0.67% yeast nitrogen
base without amino acids, 2% glucose) with appropriate auxotrophic supple-
ments. S. pombe strains were grown in YEA (0.5% yeast extract, 0.0075%
adenine, 3% glucose) or in synthetic medium PM (0.3% phallic acid, 0.018%
sodium phosphate, 0.5% ammonia chloride, 2% glucose, and PM vitamins,
minerals, and salts) with appropriate auxotrophic supplements. Standard lithium
acetate transformation protocols were used to introduce plasmids into both S.
cerevisiae and S. pombe cells (20).
Detection of protein complex formation by the two-hybrid system. To deter-
mine if GAD-Byr2-Reg (Byr2 regulatory domain) interacts with LBD-Byr2-Cat
(Byr2 kinase catalytic domain) in the two-hybrid system, the two fusions were
coexpressed in two-hybrid reporter strain L40. Cells containing these two plas-
mids were patched on synthetic medium lacking leucine and tryptophan (DO-
Leu-Trp). The patches were then examined for histidine prototrophy as well as
b-galactosidase synthesis, since two-hybrid interactions result in transactivation
of GAL1-HIS3 and lexA-lacZ. Histidine prototrophy was tested by replicating
patches onto DO-Leu-Trp-His plates and was evident by growth on the His2
plate. b-Galactosidase filter assays were conducted as previously described (37).
Furthermore, in the b-galactosidase liquid assay, cell lysates were prepared in Z
buffer, and b-galactosidase activities in these lysates were determined colori-
metrically by using o-nitrophenyl-b-D-galactopyranoside (ONPG) (17).
Generation of Byr2-Reg deletion mutants by PCR. PCR (30) was performed to
generate Byr2-Reg deletion mutants. The primers used in the PCR were the
following: 59-CGGAATTCTATGGAATATTATACCTCG-39, the 59 oligonucle-
otide used in PCR to synthesize fragments starting at amino acid residue 1;
59-GGAATTCTTTAACCTTGCCTTTACTG-39, the 59 oligonucleotide used to
synthesize fragments starting at amino acid residue 34; 59-GGAATTCCACC
GCCAAAGGCAAACAA-39, the 59 oligonucleotide used for fragments starting
at amino acid residue 51; 59-GGAATTCATGTATACTGAGGTTTATT-39, the
59 oligonucleotide used for fragments starting at amino acid residue 71; 59-GG
AATTCGCCTTGTCCATCGTTTGAA-39, the 59 oligonucleotide used for frag-
ments starting at amino acid residue 151; 59-GGAATTCTAATTCATCTT
CACCGGAA-39, the 59 oligonucleotide used for fragments starting at amino
acid residue 134; 59-GGAATTCATTGGCTCAACCGGCAGCA-39, the 59 oligo-
nucleotide used for fragments starting at amino acid residue 167; 59-GGAATT
CGGATCCTAAAACCTCAGTATACATGG-39, the 39 oligonucleotide used in
PCR to synthesize fragments ending at amino acid residue 70; 59-GGAATT
CATCGGCGGAGGTCTTCAAA-39, the 39 oligonucleotide used for fragments
ending at amino acid residue 160; 59-GGAATTCAAGGAGAAAGGGAGG
ACTG-39, the 39 oligonucleotide used for fragments ending at amino acid resi-
due 180; 59-GGAATTCATTTCGCATTATTTGAGCG-39, the 39 oligonucleo-
tide used for fragments ending at amino acid residue 200; 59-GGAATTCAAAA
ATCGGAAACTCTAGA-39, the 39 oligonucleotide used for fragments ending
at amino acid residue 220; 59-GGAATTCAGTTTCTACGAAGAGAGTT-39,
the 39 oligonucleotide used for fragments ending at amino acid residue 240;
59-GGAATTCAAATCCTCAGAGAGGAAAG-39, the 39 oligonucleotide used
for fragments ending at amino acid residue 260; 59-GGAATTCAAATCCTCA
GAGAGGAAAG-39, the 39 oligonucleotide used for fragments ending at amino
acid residue 280; 59-GGAATTCAAAGTGGAGGATCAAATCC-39, the 39 oli-
gonucleotide used for fragments ending at amino acid residue 300; and 59-GG
AATTCACATGGTTATGGATTTTTG-39, the 39 oligonucleotide used for frag-
ments ending at amino acid residue 320. PCR fragments that encode Byr2
deletion mutants were excised with EcoRI to expose the EcoRI sites at both ends
and were cloned in pGAD vector to generate GAD (GAL4 transcription acti-
vation domain) fusions. Orientation of these clones was ascertained by restriction
enzyme digestion using intrinsic sites such as XhoI.
Construction of Byr2-Reg mutant library. Byr2-Reg was randomly mutage-
nized by a standard PCR procedure (44) using primer pair 59-CACCCACTT
TCCGGATCCTATGGAATATTA-39 (shown in boldface is the BamHI site,
which is in frame with GAD) and 59-TATCCATTTGGTCGACTGATCATC
AG-39 (shown in boldface is the SalI site, which is also in frame with GAD).
pUC119-Byr2wt was used as a template for the PCR random mutagenesis. The
PCR products were gel purified and ligated into pGAD vector to create in-frame
fusions with GAD. The resulting pGAD-Byr2-Reg mutant library had a com-
plexity of over 106 clones.
We also generated a Byr2 mutant library with only the N-terminal 196 amino
acids, which encode Ste4 and Ras1 binding domains, mutagenized. To facilitate
cloning, an SfuI site was silently introduced between amino acid residues 196 and
197 of the regulatory domain of Byr2. This was achieved by changing CGC TCA
to CGT TCG by a PCR-based DNA manipulation technique. The N-terminal
stretch of 196 amino acids was generated by PCR using primer pair 59-CACC
CACTTTCCGGATCCTATGGAATATTA-39 and 59-TTTCGCATTATTCGA
ACGGACACTTCGTTT-39. The stretch from amino acids 197 to 392 of Byr2
was generated by PCR using primer pair 59-AAACGAAGTGTCCGTTCGAA
TAATGCGAAA-39 and 59-TATCCATTTGGTCGACTGATCATCAG-39. The
N-terminal 196-amino-acid fragment was digested by BamHI-SfuI, and the other
fragment encoding amino acids 197 to 392 was digested with SfuI-SalI. They were
ligated together to form the entire Byr2 regulatory domain and cloned into
pGAD and pLBD as a BamHI-SalI fragment. The end products were sequenced,
and no undesirable alteration was found. With the creation of the SfuI site, the
N-terminal 196 amino acids were then subjected to PCR random mutagenesis.
The pool of mutants was excised with BamHI and SfuI and rejoined with the rest
of Byr2-Reg to form the entire Byr2-Reg clones in pLBD. The complexity of the
library was determined to be approximately 5 3 105 clones.
S. pombe expression constructs. Full-length clones of Byr2 in pLBD were
made by inserting BamHI-SalI fragments of Byr2-Reg into pLBD-Byr2-Cat,
which contains a SalI-SacI/PstI Byr2-Cat (kinase catalytic domain) fragment.
They were then excised as BamHI-SacI fragments and cloned immediately down-
stream of the adh promoter in S. pombe expression vectors pART1 and pAAU1.
pART1, an ARS LEU2-based plasmid, was used to introduce Byr2 to SP4A,
SP4AD, SPRUD, SPSU, and SPSUD. pAAU1, an ARS ura4-based plasmid, was
used as an expression vehicle in SP4A, SP4AD, and SPGLD.
S. pombe sporulation assay. S. pombe sporulation assays were conducted in the
following fashion. Clones of Byr2 were transformed into yeast strains by the
lithium acetate transformation protocol. Yeast transformants were selected in
PM synthetic medium with appropriate auxotrophic supplements. After 4 or 5
days of incubation at 30°C, colonies were patched onto fresh PM plates, and after
another 3 days of incubation at 30°C, the patches were examined microscopically
and the number of asci in total cells was determined. At least 12 patches were
tested for each plasmid and strain pair, and an average was taken.
Generating plasmids to express Ste4 and Ras1 in two-hybrid interaction
study. pLS104, a 2mm ADE2-based plasmid, was used to express Ste4 and Ras1
in two-hybrid reporter strains. pLS104 was made and kindly provided by Siyuan
Le at Cold Spring Harbor Laboratory. Ste4 and Ras1 were inserted immediately
downstream of the adh promoter to generate pLS104-Ste4 and pLS104-Ras1.
YCp405, a LYS2-based S. cerevisiae CEN plasmid (25), was used to introduce
Ras1 along with Ste4. YCp405-Ras1 was made by cloning the SphI fragment
from pLS104-Ras1 that contains the adh promoter-Ras1-adh terminator into
YCp405.
Cloning of a dominant activated Shk1 gene from an S. pombe cDNA library by
PCR. PCR was performed to isolate N-terminally truncated Shk1. An S. pombe
cDNA library, kindly provided by Jim Hudson at Cold Spring Harbor Labora-
tory, was used as the source of template. Oligonucleotides 59-GAGGATCC
CATGGTTAAAACTACTACCTCTAATGCT-39 and 59-AAGGATCCCTGC
AGCTATTTACCAGAATGATGTATGGA-39 were used to isolate the C-ter-
minal 385 amino acids of Shk1. To combine the amplification power of Taq DNA
polymerase and the high fidelity of Pfu polymerase (Stratagene) in nucleotide
incorporation, the PCR was performed in two steps. First, Taq DNA polymerase
was used for 10 cycles of PCR. DNA was extracted from the reaction mixtures by
using a Qia-quick PCR purification kit (Qiagen). The total DNA was then used
TABLE 1. Yeast strains used in this study
Strain Relevant genotype Source orreference
S. cerevisiae
HF7C MATa ura3-52 his3-200 lys2-801
ade2-101 trp1-901 leu2-3,112 gal4-
542 gal80-538 LYS2::GAL1-HIS3
URA3::(GAL4 17-mers)3-CYC-lacZ
H. Feilotter
L40 MATa ade2 his3 leu2 trp1 LYS::lexA-
HIS3 URA3::lexA-lacZ
A. Vojtek
YCJ4 MATa ura3-52 his3-200 leu2-3,-112
trp1-901 Canr gal4-542 gal80-538
ade2::GAL1-URA3 lys2::lexAop-lacZ
T. Durfee
S. pombe
SP870 h90 leu1-32 ade6-210 ura4-D18
haploid
D. Beach
SP4A h90 leu1-32 ade6-210 ura4-D18
ste4::ADE2 haploid
Barr et al. (3)
SP4AD h90 leu1-32 ade6-210 ura4-D18
ste4::ADE2 diploid
Barr et al. (3)
SPRUD h90 leu1-32 ade6-210 ura4-D18
ras1::ura4 diploid
Wang et al. (38)
SPSU h90 leu1-32 ade6-210 ura4-D18
byr2::ura4 haploid
Wang et al. (38)
SPSUD h90 leu1-32 ade6-210 ura4-D18
byr2::ura4 diploid
Wang et al. (38)
SPGLD h90 leu1-32 ade6-210 ura4-D18
gpa1::LEU2 diploid
Neiman et al. (31)
SPBUD h90 leu1-32 ade6-210 ura4-D18
byr1::ura4 diploid
Wang et al. (38)
VOL. 17, 1997 MULTIPLE REGULATORY DOMAINS ON Byr2 PROTEIN KINASE 5877
 o
n
 April 6, 2012 by M
AIN LIBRARY
http://m
cb.asm
.org/
D
ow
nloaded from
 
as a template for 25 cycles of PCR with Pfu DNA polymerase. The reaction
mixture was subjected to electrophoresis, and a 1.2-kb DNA fragment was
excised with BamHI and PstI and cloned into pLS104. Forty-four clones were
isolated. The first eight clones were sequenced, and all were found to encode the
C-terminal 385 amino acids of S. pombe Shk1. The kinase-defective Shk1DN,
Shk1K415,416RDN, was made with two adjacent critical lysine residues changed to
arginine by PCR site-directed mutagenesis using Pfu DNA polymerase (16). The
following four oligonucleotides were used: 59-GAGGATCCCATGGTTAAAA
CTACTACCTCTAATGCT-39, 59-AAGGATCCCTGCAGCTATTTACCAGA
ATGATGTATGGA-39, 59-TGGCTGTTGATTAATGTTCATTCTCCTGATG
GCAACAGAAAGATTAGT-39, and 59-ACTAATCCTTCTGTTGCCATCAG
GAGAATGAACATTAATCAACAGCCA-39. The end product was excised
with BamHI and PstI and cloned into pLS104.
Isolation of Byr1 mutants that bind the Byr2 kinase catalytic domain effec-
tively. Wild-type Byr1 binds very weakly with the Byr2 kinase catalytic domain in
the two-hybrid system. To conduct a two-hybrid interaction study with Byr1, we
needed a Byr1 mutant that binds the Byr2 kinase catalytic domain more effec-
tively. Thus, we decided to screen for such a mutant with the two-hybrid system.
A pool of Byr1 mutants was generated by PCR mutagenesis using our standard
protocol. They were cloned into pGAD vector. The DNA of this mutant library
was then cotransformed with pLBD-Byr2-Cat into strain L40. In order to select
those that can bind pLBD-Byr2-Cat effectively, cells were plated onto DO-Leu-
Trp-His. Colonies that grew in the absence of histidine were patched out and
subjected to a 5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside (X-Gal) filter
assay. pGAD plasmids were recovered from the cells that were His1 and LacZ1.
The DNAs of these plasmids were amplified in E. coli and then transformed back
into L40 individually with pLBD-Byr2-Cat or pLBD-Lamin to test the specificity
and reproducibility of the interaction. More than 10 independent clones were
isolated in this way. One of them encoded Byr1EBB-1 (EBB stands for effectively
binding to Byr2) and was used in testing the kinase configuration model with the
two-hybrid system.
RESULTS
Interaction between the regulatory and catalytic domains of
Byr2 in the two-hybrid system. There are many examples of
protein kinases in which a regulatory domain binds to and
inhibits the catalytic domain (35). To our knowledge, this has
not yet been demonstrated for MEKKs. To test this hypothesis
for Byr2, the two-hybrid system was used. The regulatory do-
main of Byr2, Byr2-Reg, was isolated by PCR and fused to
GAD to generate GAD-Byr2-Reg (Fig. 1 illustrates the no-
menclature used in this paper). Byr2-Cat, was isolated by PCR
and fused to LBD (lexA DNA binding domain) to generate
LBD-Byr2-Cat. pGAD-Byr2-Reg and pLBD-Byr2-Cat were
cotransformed into the S. cerevisiae two-hybrid strain L40.
GAD, LBD-Ras1, and LBD-Lamin were used as controls. In-
teractions between the GAD fusion and the LBD fusion result
in histidine prototrophy and synthesis of b-galactosidase (see
FIG. 1. Schematic illustration of Byr2, Shk1, and Byr1 wild-type proteins, domains, and mutants used in this study. Byr2-SBD, the Ste4 binding domain on Byr2,
encodes amino acids 1 to 70; Byr2-RBD, the Ras1 binding domain, encodes amino acids 71 to 180; and Byr2-CBD, the catalytic binding domain, encodes amino acids
151 to 260. p, point mutations. The Byr2FBS mutant tested has a N28I point mutation, and the Byr2FBR mutant has a K101E mutation. Shk1DN is the C-terminal 385
amino acids of the Shk1 protein.
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Materials and Methods). The two-hybrid interaction results
are shown in Fig. 2. Cells containing the pair pGAD-Byr2-Reg
and pLBD-Ras1 or the pair pGAD-Byr2-Reg and pLBD-Byr2-
Cat were able to grow on medium lacking histidine and tested
positive for b-galactosidase activity. Cells with the pair pGAD-
Byr2-Reg and pLBD-Ras1 grew better on media lacking his-
tidine and synthesized more b-galactosidase, as indicated by
X-Gal filter assay, than those with the pair pGAD-Byr2-Reg
and pLBD-Byr2-Cat. Cells containing the pair pGAD-Byr2-
Reg and pLBD-Lamin failed to grow on medium lacking his-
tidine and tested negative for b-galactosidase activity; also,
cells containing LBD-Ras1 or LBD-Byr2-Cat with GAD failed
to grow in the absence of histidine and had no detectable
b-galactosidase activity (data not shown in the figure). These
controls demonstrated the specificity of the two-hybrid inter-
action between Byr2-Reg and Byr2-Cat. Thus, besides binding
Ste4 and Ras1, the Byr2 regulatory domain also binds the Byr2
kinase catalytic domain in the two-hybrid system.
Delimitation of three interaction domains. To identify re-
gions on the Byr2 regulatory domain that are responsible for
each of the three interactions, a series of Byr2-Reg deletion
mutants were generated systematically by PCR (see Materials
and Methods) and were fused individually with GAD. GAD-
Byr2-Reg is capable of binding LBD-Ras1 and LBD-Byr2-Cat
in strain L40 and GBD-Ste4 (GBD stands for GAL4 DNA
binding domain) in another S. cerevisiae strain, HF7C. There-
fore, the deletion mutants were tested for their ability to bind
LBD-Ras1 and LBD-Byr2-Cat in L40 and GBD-Ste4 in HF7C.
The shortest peptides that could bind partner proteins as ef-
fectively as could Byr2-Reg in the two-hybrid interaction assays
were considered the interaction domains. The data are sum-
marized in Fig. 3, and a portion of the actual data is shown in
Fig. 2. Clone BDM1 (Byr2 deletion mutant 1), encoding the
N-terminal 70 amino acids of Byr2, was the shortest peptide
that could bind Ste4 in the two-hybrid system. It failed to bind
Ras1 or Byr2-Cat, and therefore it was considered to encode
the Ste4 binding domain (Byr2-SBD). Clone BDM13, encod-
ing a stretch of 110 amino acids from C71 to P180 of Byr2, was
the shortest one that retained Ras1 binding ability in the two-
hybrid system. This domain failed to bind Ste4 or Byr2-Cat and
thus was designated the Ras binding domain (Byr2-RBD).
Further truncations from either the N-terminal or the C-ter-
minal boundary of clone BDM13 resulted in loss of Ras1
binding ability, as indicated by clones BDM12 and BDM16.
Clone BDM21, encoding 110 amino acids of Byr2 ranging from
P151 to L260, was the shortest one that could bind Byr2-Cat
but not Ste4 or Ras1 in the two-hybrid system and thus was
designated the catalytic binding domain (Byr2-CBD). Clone
BDM21 in fact appears to bind the catalytic region better than
the full regulatory region (Fig. 2). Although clone BDM21 may
not be the exact minimum binding domain, it must be fairly
close, since further trimming resulted in peptides that fail to
bind Byr2-Cat, as indicated by clones BDM23 and BDM4.
These results demonstrated that three distinctive binding do-
mains on Byr2-Reg are responsible for binding Ste4, Ras1, and
Byr2-Cat. The domain for Ste4 binding is completely separable
from the domains responsible for binding Ras1 and Byr2-Cat,
which overlap by 30 amino acids.
Isolation of Byr2-Reg mutants that fail exclusively to bind
Ste4, Ras1, or Byr2-Cat. To enable us to evaluate the physio-
FIG. 2. Two-hybrid interaction profile of domains of Byr2 and mutants with alterations in these domains. GAD-Byr2-Reg, GAD-Byr2-SBD, GAD-Byr2-RBD,
GAD-Byr2-CBD, GAD-Byr2FBS-Reg (a Byr2-Reg N28I mutant), GAD-Byr2FBR-Reg (a Byr2-Reg K101E mutant), GAD-Byr2FBC-Reg (a Byr2-Reg F221S mutant),
and GAD-Byr2P209S-Reg were transformed individually with LBD-Ras1, LBD-Byr2-Cat, and LBD-Lamin in strain L40 and with GBD-Ste4 and GBD in strain HF7C.
Transformants were tested for their ability to grow on media lacking histidine and assayed for b-galactosidase expression. Values shown are relative levels (means 6
standard deviations). DO-LT and DO-LTH are DO-Leu-Trp and DO-Leu-Trp-His, respectively.
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logical significance of the interaction between Ste4 and the
Byr2 regulatory domain, we screened for Byr2 mutants that
failed exclusively to bind Ste4 (Byr2FBS) so that we could
examine them for their activities in comparison with the wild-
type kinase. In this way, we could also independently confirm
the location of the Ste4 binding domain. We mutagenized
Byr2-Reg by PCR random mutagenesis and generated a library
of pLBD-Byr2-Reg mutants which was cotransformed with
pGAD-Ste4 into S. cerevisiae L40. The cells were plated on
DO-Leu-Trp to ensure that transformants had both GAD and
LBD fusions. Transformants that failed to transactivate b-
galactosidase were isolated. Plasmids encoding these mutants
FIG. 3. Delimitation of domains on Byr2-Reg responsible for each of the three interactions. A series of Byr2 deletion mutants were made by PCR. They were
assayed for two-hybrid interaction with Ste4, Ras1, and the kinase catalytic domain of Byr2. 1, positive two-hybrid interaction that is at least as strong as that with
Byr2-Reg; 2, no detectable two-hybrid interaction. The peptide sequences expressed as GAD fusions are shown (gray rectangles), with amino acid positions indicated.
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were then cotransformed individually into L40 with pGAD-
Ste4 or pGAD-Ras1. Ten Byr2-Reg mutants that were able to
transactivate lacZ and HIS3 reporter genes with Ras1 but not
Ste4 were then recloned into pGAD vector and tested for
two-hybrid interaction with pLBD-Byr2-Cat. They all could
bind LBD-Byr2-Cat as effectively as could wild-type Byr2-Reg.
DNA sequencing revealed that all 10 mutants have mutations
between amino acids N28 and G47, which locate inside the
Ste4 binding domain (Byr2-SBD). Some mutants, such as L35P
(with a leucine-to-proline change at position 35), were isolated
multiple times. For more information, see Table 2, and see Fig.
2 for representative data.
Similarly, to enable us to test if the physical association
between Byr2-Reg and Byr2-Cat is physiologically relevant, we
looked for Byr2-Reg mutants that fail to bind Byr2-Cat but are
still able to bind Ste4 and Ras1 (Byr2FBC mutants). An S.
cerevisiae two-hybrid strain with GAL1-URA3 and lexA-lacZ
dual reporters, YCJ4 (19), was used so that the interactions
between Byr2-Reg and Ras1 and between Byr2-Reg and Byr2-
Cat could be examined simultaneously in the same cells. YCJ4
was transformed with a pGAD-Byr2-Reg mutant library,
pLBD-Byr2-Cat, and pHT3601-Ras1, which expresses a GBD-
Ras1 fusion and an ADE2 auxotrophic marker. Cells were
plated on synthetic medium lacking leucine (for pGAD selec-
tion), tryptophan (for pLBD selection), adenine (for pHT3601
selection), and uracil (for transactivation of GAL1-URA3 re-
porter construct, which results from the two-hybrid interaction
between Byr2-Reg and Ras1). Transformants were tested for
transactivation of the lacZ reporter gene, and those that tested
negative were isolated. pGAD-Byr2-Reg mutants were recov-
ered from these cells. They were then reexamined in strain L40
with pLBD-Ras1 and pLBD-Byr2-Cat and in strain HF7C with
pGBD-Ste4 for Ste4 interaction. Results obtained for L40 and
HF7C were completely consistent with those for YCJ4. This
demonstrated that the dual-reporter strain is functional.
Eleven mutants consistently failed to bind Byr2-Cat but re-
tained Ras1 and Ste4 binding abilities at normal levels. DNA
sequencing revealed that all mutants have mutations from
P202 to S235, which reside within the domain that is respon-
sible for binding the kinase catalytic domain (Byr2-CBD). Mu-
tations such as F221S were also encountered multiple times.
Additional information and representative data are shown in
Table 2 and Fig. 2.
To enable us to characterize the functions that are depen-
dent on the physical interaction between Ras1 and Byr2, we
searched for Byr2 mutants that fail to bind Ras1 specifically
(Byr2FBR mutants). The DNA encoding the first 196 amino
acids of Byr2, which are responsible for Ste4 and Ras1 binding,
was randomly mutagenized by PCR. The mutant pool was
fused to the rest of Byr2 to generate a full-length Byr2 regu-
latory domain in pLBD (see Materials and Methods). The
DNA of the mutant library was transformed into L40 with
pGAD-Ras1. More than 10,000 colonies were subjected to
b-galactosidase filter assay, and 150 potentially interesting mu-
tants were isolated. These pLBD-Byr2-Reg mutants were
tested again with pGAD-Ras1 and pGAD-Ste4, and five mu-
tants that failed to bind pGAD-Ras1 completely but were able
to bind Ste4 as efficiently as was wild-type Byr2-Reg were
isolated. These five Byr2-Reg mutants were cloned in the
pGAD vector and were tested for two-hybrid binding with
LBD-Byr2-Cat. Only one of these five mutants was also able to
bind Byr2-Cat (Fig. 2). This result is consistent with an overlap
in the Ras1 and Byr2-Cat binding domains. DNA sequencing
revealed that this mutant contains a point mutation, K101E,
which localizes within the Byr2 Ras1 binding domain.
These mutants confirm the results of our deletion mapping
of the Byr2 interaction domains and give us reagents with
which we can explore the physiological significance of these
interactions.
Two-hybrid interaction profile of an activated Byr2 mutant,
Byr2P209S. An activated Byr2 mutant, Byr2P209S, was investi-
gated to see if its two-hybrid interaction profile is different
from that of the wild-type kinase. Byr2P209S, which has a point
mutation resulting in a serine substitution for proline on resi-
due 209 within Byr2-CBD, was made by site-directed mutagen-
esis in a previous study (31). The P209S mutation is structurally
equivalent to an activating P279S mutation of STE11 of S.
cerevisiae (36), because the six amino acids flanking the proline
are shared by Byr2 and STE11 even though the rest of the
kinase regulatory domains of these two genes show little ho-
mology. Neiman et al. have shown that overexpression of
Byr2P209S could rescue the sporulation defect of gpa1null cells
more effectively than could the overexpression of wild-type
Byr2 (31).
The regulatory domain of Byr2P209S, Byr2P209S-Reg, was iso-
lated by PCR and was cloned into pGAD and pLBD vectors.
pGAD-Byr2P209S-Reg was cotransformed into L40 with pLBD-
Ras1, pLBD-Byr2-Cat, and pLBD-Lamin individually. Trans-
formants were then tested for the transactivation of lacZ and
HIS3 reporter genes. pGAD-Byr2-Reg was tested in parallel
for comparison. Byr2P209S-Reg was able to bind Ras1 as effi-
ciently as was wild-type Byr2-Reg (Fig. 2). However, it com-
pletely failed to bind Byr2-Cat. Byr2P209S-Reg was also tested
in S. cerevisiae HF7C with Ste4 and was found to be able to
bind Ste4 as well as did wild-type Byr2-Reg. Thus, the P209S
mutation appears to abolish specifically the interaction be-
tween Byr2-Reg and Byr2-Cat. This finding suggests a link
between Byr2 intramolecular interaction and kinase autoreg-
ulation.
TABLE 2. Sequence information for Byr2-Reg mutants
that fail to bind Ste4 or Byr2-Cat
Mutant Original amino acid Residue no. New amino acid
Byr2FBS mutants
Byr2FBS-1 L 35 P
D 90 H
Byr2FBS-2 G 47 R
F 57 Y
Byr2FBS-3 L 46 Q
R 69 C
Byr2FBS-4 L 35 P
Byr2FBS-5 L 46 P
Byr2FBS-6 L 40 S
Byr2FBS-7 L 46 Q
Byr2FBS-8 L 46 P
Byr2FBS-9 N 28 S
F 57 S
Byr2FBS-10 N 28 I
Byr2FBC mutants
Byr2FBC-1 F 221 S
Byr2FBC-2 I 229 P
Byr2FBC-3 P 223 S
Byr2FBC-4 L 213 P
Byr2FBC-5 F 203 S
Byr2FBC-6 F 221 S
Byr2FBC-7 P 202 L
I 214 T
Byr2FBC-8 F 203 S
Byr2FBC-9 L 213 P
Byr2FBC-10 S 235 P
Byr2FBC-11 I 214 M
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Genetic analysis of domain mutants. Upon nitrogen starva-
tion, S. pombe haploid cells conjugate with cells of the opposite
mating type and form diploid cells. If nitrogen starvation per-
sists, diploid cells typically undergo meiosis followed immedi-
ately by sporulation, in which four spores (haploid cells) are
produced, forming a zygotic ascus. We monitor the production
of zygotic spores to assay the ability of haploid cells to conju-
gate.
If nitrogen sources are introduced immediately after conju-
gation, newly formed diploid cells can be propagated asexually
without entering meiosis. When starved for nitrogen, these di-
ploid cells are induced to enter meiosis and sporulate, a pro-
cess that requires the same components of the sexual differ-
entiation pathway as conjugation (reviewed in reference 9). In
this case, azygotic spores form. We can thus assay the func-
tionality of the sexual differentiation signaling pathway by de-
priving diploid cells of nitrogen sources and monitoring azy-
gotic sporulation.
In both cases, whether sexual functions are monitored in
haploid or diploid cells, the ability of the cells to sporulate is
measured by determining the percentage of sporulated cells.
Sporulation of diploid cells is a less stringent test for the in-
tegrity of the pathway than conjugation and subsequent sporu-
lation.
S. pombe cells that lose the function of Byr2, Ste4, Ras1, or
Gpa1 are defective in mating and sporulation. Wild-type Byr2
acts, to various extents, as a high-copy-number suppressor of
these defects. By comparing Byr2 mutants with wild-type Byr2
as high-copy-number suppressors, we can begin to analyze the
physiological significance of each interaction involving Byr2.
As a starting point, haploid cells deficient in Byr2, Ste4, Ras1,
or Gpa1 fail to mate (less than 0.01%; see Materials and
Methods for a description of the sporulation assay). Introduc-
tion of a high-copy-number plasmid expressing the wild-type
Byr2 gene yields 60% zygotic spores (percentage of total cells)
in byr2null cells and 0.5% in ste4null cells but none in ras1null or
gpa1null cells (Table 3). Diploid cells deficient in Byr2, Ste4, or
Gpa1 are unable to sporulate, and those deficient in Ras1 can
sporulate only at a level of about 1.5%. Overexpression of the
wild-type Byr2 gene dramatically increases sporulation effi-
ciency in these cells: 80% in byr2null diploid cells, 5% in ste4null
diploid cells, 35% in ras1null diploid cells, and 0.5% in gpa1null
diploid cells.
One Byr2FBS (fails to bind Ste4) mutant, which contains a
N28I point mutation, was tested and compared with wild-type
Byr2 for its ability to act as a high-copy-number suppressor for
sporulation defects. It was transformed into byr2null haploid
cells and diploid cells, ste4null haploid cells and diploid cells,
and ras1null diploid cells. The cells were plated on synthetic
medium with appropriate auxotrophic supplements. After 4 or
5 days of incubation at 30°C, transformants were patched onto
fresh plates. After an additional 3 days of incubation, the
patches were examined microscopically for the percentage of
asci. The averages from more than 10 patches are presented in
Table 3. In byr2null haploid cells and diploid cells, Byr2FBS
yielded about 1 to 2% asci, which is 50-fold less than the value
for wild-type Byr2. In ste4null haploid cells and diploid cells,
Byr2FBS was comparable to wild-type Byr2. It yielded about
0.2% zygotic asci in ste4null haploid cells and about 2% azygotic
asci in ste4null diploid cells. In ras1null diploid cells, however, it
yielded only about 3.5% azygotic asci, about 10-fold less than
the value for wild-type Byr2. The diminished ability of Byr2FBS
to complement these mutants indicates that the interaction
between Byr2 and Ste4 is required for normal function. This
interaction is irrelevant when Ste4 itself is missing, indicating
that the Byr2FBS mutant has no other defect besides the failure
to bind Ste4.
Byr2FBR, which contains a K101E point mutation and fails to
bind Ras1, was tested similarly. It was expressed in byr2null
haploid cells and diploid cells, ste4null haploid cells and diploid
cells, and ras1null diploid cells. Like Byr2FBS, Byr2FBR yielded
only 1 to 2% asci in byr2null cells. However, it failed to yield any
spores in ste4null cells, whereas it behaved similarly to wild-type
Byr2 in ras1null cells, yielding about 35% asci. These results
suggest that the interaction between Byr2 and Ras1 is neces-
sary for the proper function of Byr2 and that Byr2FBR is de-
fective only in this interaction.
Byr2P209S and four Byr2FBC mutants, containing F221S,
I229P, P223S, and P213S mutations and failing to bind the
catalytic domain, were tested in similar fashion. They were
TABLE 3. Suppression of mating and/or sporulation defects in ste4null, ras1null, byr2null, and gpa1null haploid or
diploid cells by overexpression of Byr2 mutantsa
Mutant
% Asci in total cells
ste4null
ras1null diploid
byr2null
gpa1null diploid
Haploid Diploid Haploid Diploid
None (vector alone) ,0.01 ,0.01 1.5 6 0.3 ,0.01 ,0.01 ,0.01
Byr2wt 0.5 6 0.3 4.8 6 0.8 33.8 6 2.5 54.2 6 7.2 75.0 6 3.5 0.4 6 0.2
Byr2P209S 14.3 6 4.3 22.3 6 6.1 35.0 6 3.5 61.7 6 2.9 78.3 6 2.9 21.4 6 4.8
Byr2FBC-1 13.0 6 4.2 30.0 6 3.5 NDb ND ND 23.5 6 4.8
Byr2FBC-2 ND ND ND ND ND 24.1 6 3.3
Byr2FBC-3 ND ND ND ND ND 24.1 6 4.3
Byr2FBC-4 ND ND ND ND ND 23.1 6 2.9
Byr2FBS 0.3 6 0.1 2.4 6 1.6 3.2 6 0.6 1.6 6 0.9 1.3 6 0.6 ND
Byr2FBR ,0.01 0.4 6 0.3 33.7 6 2.9 1.1 6 0.5 1.6 6 0.6 ND
Byr2FBS-FBR ,0.01 0.3 6 0.2 ND ,0.01 ,0.01 ND
Byr2FBS-P209S 14.8 6 0.4 27.2 6 2.2 ND 64.0 6 4.2 82.0 6 5.7 ND
a ste4null, ras1null, and byr2null haploid and/or diploid cells were transformed with pART1-Byr2wt, pART1-Byr2P209S, pART1-Byr2FBC-1, pART1-Byr2FBS, pART1-
Byr2FBR, pART1-Byr2FBS-FBR, pART1-Byr2FBS-P209S, or pART1 vector alone. gpa1null diploid cells were transformed with pAAU1-Byr2wt, pAAU1-Byr2P209S, four
different pAAU1-Byr2FBC mutants, or pAAU1 vector alone. Transformants were selected in synthetic medium with appropriate auxotrophic supplements on plates.
After 4 or 5 days of incubation at 30°C, colonies were patched onto fresh plates. After another 3 days of incubation at 30°C, when the cells start to undergo nitrogen
starvation, the patches were examined microscopically and the percentages of asci in the total cell populations were determined. At least 104 cells were examined for
each entry in the table. The percentages shown in the table are averages from at least 10 colonial patches.
b ND, not determined.
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transformed into byr2null haploid cells and diploid cells, ste4null
haploid cells and diploid cells, ras1null diploid cells, and gpa1null
diploid cells. Byr2P209S behaved indistinguishably from the
Byr2FBC mutants, and they all were superior to wild-type Byr2
as high-copy-number suppressors in ste4null and gpa1null cells.
They yielded about 15% zygotic asci and about 20% azygotic
asci in ste4null haploid cells and diploid cells, respectively,
which is 4- to 30-fold higher than the values for wild-type Byr2.
They yielded about 20% azygotic asci in gpa1null diploid cells,
40-fold higher than the value for wild-type Byr2. Byr2FBC mu-
tants behaved similarly to wild-type Byr2 in complementing the
sexual defects of byr2null and ras1null cells. These data suggest
that Byr2P209S is indeed in the same group as Byr2FBC and that
the abrogation of the interaction between the Byr2 regulatory
and kinase domains appears to result in Byr2 activation.
Two double mutants, Byr2FBS-FBR, which contains both
N28I and K101E mutations, and Byr2FBS-P209S, which contains
both N28I and P209S mutations, were tested similarly in the
sporulation assay. They were made by joining together Byr2
fragments containing each mutation. They were expressed in
byr2null haploid cells and diploid cells, ste4null haploid cells and
diploid cells, and ras1null diploid cells. The Byr2FBS-FBR mutant
was a very poor suppressor for all strains tested. It failed to
effectively rescue the sexual defects of byr2null, ste4null, or
ras1null cells. This result confirms the notion that both Ste4
binding and Ras1 binding are required for proper Byr2 func-
tion. The Byr2FBS-P209S mutant, however, behaved like the
Byr2P209S single mutant in the sporulation assay. It yielded
about 60 to 80% asci in byr2null cells, 15 to 25% asci in ste4null
cells, and 35% asci in ras1null cells. This result confirms that
Byr2P209S is more active than wild-type Byr2. It also further
confirms that the release of Byr2 autoinhibition bypasses the
requirement for Ste4 interaction under these conditions.
To ensure that the increased activity of Byr2P209S which we
observed is due to its effects on the MAPK pathway, we tested
whether Byr2P209S could bypass Byr1, which functions down-
stream of Byr2. Overexpression of wild-type Byr2 cannot res-
cue the sporulation defect of byr1null cells (38). pART1CM,
pART1CM-Byr2, pART1CM-Byr2P209S, and pART1CM-Byr1
were transformed into SPBUD, an S. pombe byr1null diploid
strain. Transformants were tested in the sporulation assay.
As expected, cells expressing Byr1 yielded about 50%
spores, while those expressing vector alone, wild-type Byr2,
or Byr2P209S had no spores. Moreover, to ensure that the
increased activity of Byr2P209S was the result of its altered
regulation and not the result of a change in protein stability, we
checked the protein expression level of Byr2P209S in compari-
son with that of wild-type Byr2. 9E10 epitope-tagged Byr2,
Byr2P209S, and Byr1 were expressed in SPBUD. Transformants
were grown in PM medium, and cells were harvested when the
culture became turbid. Equal amounts of cells were taken and
were extracted in 0.5% sodium dodecyl sulfate (SDS) by vor-
texing with glass beads. The cell extracts were boiled with SDS
sample buffer, cleared, and subjected to SDS-polyacrylamide
gel electrophoresis followed by Coomassie blue staining and
Western blot analysis with 9E10 monoclonal antibodies (data
not shown). Bands at 80 kDa were found specifically in the
lanes from cells expressing 9E10-Byr2 or 9E10-Byr2P209S. The
intensities of the bands were indistinguishable. This experi-
ment rules out the possibility that the P209S mutation activates
Byr2 by enhancing the stability of the protein.
Two-hybrid assay for an open configuration of Byr2. From
our studies of the isolated Byr2 regulatory and kinase domains,
we concluded that they interact in the two-hybrid system and
that point mutations in the regulatory domain, such as P209S,
disrupt this interaction. Thus, we suspected that wild-type Byr2
might exist in a closed configuration, whereas the Byr2P209S
and Byr2FBC mutants might be in an open configuration, with
the kinase catalytic domain released. Since the Byr2 kinase
domain can be recognized by both the Byr2 regulatory domain
and Byr2-CBD in the two-hybrid system, it is possible to test
this prediction. GAD-Ste4, GAD-Ras1, GAD-Byr2-Reg, GAD-
Byr2-CBD, or GAD was expressed in L40 with LBD-Byr2,
LBD-Byr2P209S, LBD-Byr2FBC-1, or LBD-Lamin. Two-hybrid
interactions again were determined by the transactivation of
HIS3 and lacZ reporter genes. Results are shown in Fig. 4.
LBD-Byr2, LBD-Byr2P209S, and LBD-Byr2FBC-1 were able to
bind GAD-Ste4 and GAD-Ras1 equally well. Byr2-Reg was
able to bind Byr2P209S and Byr2FBC-1 but not wild-type Byr2.
Byr2-CBD was able to interact very weakly with Byr2 but much
more strongly with Byr2P209S and Byr2FBC-1. This suggests that
the catalytic domain of wild-type Byr2 was restrained, whereas
that of the point mutants was released. It also shows that both
Byr2-Reg and Byr2-CBD could be used to detect the release of
Byr2-Cat. It further indicates that the interaction between
Byr2-Reg and Byr2-Cat does not significantly interfere with
Ras1 or Ste4 binding to Byr2-Reg.
To further test our hypothesis, namely, that the Byr2 regula-
tory domain binds to and inhibits access to the kinase catalytic
domain and that the P209S mutation releases this intramolec-
ular interaction, we decided to perform the same two-hybrid
experiments using GAD-Byr1. Byr1 is the presumed MEK sub-
strate for Byr2. We have observed a very weak interaction
between GAD-Byr1 and LBD-Byr2-Cat in the two-hybrid sys-
tem. To study this complex formation more clearly, a Byr1
mutant that binds the Byr2 kinase catalytic domain more ef-
fectively was sought, and found, by screening a GAD-Byr1
mutant library for clones that can establish a strong two-hybrid
interaction with LBD-Byr2-Cat (see Materials and Methods).
Fifteen mutants were isolated, and one of them, Byr1EBB-1,
was used in the two-hybrid experiments.
We first tested the two-hybrid binding between GAD-Byr1EBB-
1 and LBD-Byr2-Cat. GAD-Byr1wt and LBD-Lamin served
as negative controls. The data are presented in Fig. 5. GAD-
Byr1EBB-1 was able to bind very well with LBD-Byr2-Cat,
whereas GAD-Byr1wt binds LBD-Byr2-Cat very poorly.
GAD-Byr1EBB-1 failed to bind LBD-Lamin, establishing
the specificity of the interaction between GAD-Byr1EBB-1
and LBD-Byr2-Cat. We then tested the interaction between
GAD-Byr1EBB-1 and LBD-Byr2wt and LBD-Byr2P209S.
GAD-Byr1EBB-1 was able to bind much more effectively to
LBD-Byr2P209S than to LBD-Byr2wt, once again supporting the
notion that the kinase catalytic domain of wild-type Byr2 is
restrained whereas that of Byr2P209S is released.
Disruption of the closed configuration of Byr2 by Shk1. Our
success in monitoring the kinase configuration in the two-
hybrid system raised the possibility that we might be able to
test or even screen for signaling components that are respon-
sible for the opening of the closed configuration of wild-type
Byr2. For this purpose, we used two-hybrid testing strains con-
taining GAD-Byr2-CBD and LBD-Byr2wt. The switch from a
closed form to an open form in Byr2 would result in the
binding of GAD-Byr2-CBD to LBD-Byr2wt, detected in the
usual manner. The components we tested for opening of Byr2
were expressed from either an ADE2 based or a LYS2 based
vector or both vectors. We tested Ras1, Ste4, and Shk1. We
suspected S. pombe Shk1 to be an activator of Byr2 because it
appears to be involved in sexual differentiation in S. pombe
(33) and is a close homolog of S. cerevisiae STE20/PAK (26).
STE20 has been determined to function in the sexual differ-
entiation of S. cerevisiae, upstream of STE11 (24), which is a
close homolog of Byr2 (31). Moreover, Wu et al. have dem-
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onstrated that STE20 can directly phosphorylate STE11 in
vitro (40).
We first tested if Ste4 or Ras1 or the two together could
induce the opened configuration of Byr2. Ste4 and Ras1 are
candidates for this task because they both bind to the regula-
tory domain of Byr2, and Byr2-RBD even overlaps with Byr2-
CBD. LBD-Byr2 or LBD-Byr2P209S was expressed in L40 and
YCJ4 cells containing GAD-Byr2-CBD. A third plasmid, an
ADE2-based pLS104, was used to express Ste4 alone. A fourth
plasmid, a LYS2-based YCp405, was used to express Ras1.
Two-hybrid interaction data are presented in Fig. 6. Again,
GAD-Byr2-CBD was able to bind strongly with LBD-Byr2P209S
but only very weakly with LBD-Byr2. Expression of Ste4 or
Ras1 or the pair did not induce interaction between LBD-Byr2
and GAD-Byr2-CBD, nor did it visibly affect the interaction
between LBD-Byr2P209S and GAD-Byr2-CBD. In this experi-
ment, we failed to demonstrate that wild-type Byr2 can be
opened by Ste4 or Ras1, singly or jointly.
In contrast to the above results, Shk1, the S. pombe homolog
of S. cerevisiae STE20/PAK, can open Byr2. A dominant acti-
vated form of Shk1, Shk1DN, was isolated from an S. pombe
cDNA library by PCR (see Materials and Methods). It was
cloned into pLS104. Forty-four independent clones were ob-
tained, and the first eight were tested for their ability to induce
the interaction between GAD-Byr2-CBD or GAD-Byr1EBB-1
and the kinase catalytic domain of LBD-Byr2. A kinase-defec-
tive Shk1, Shk1K415,416RDN, was made with two adjacent crit-
ical lysine residues changed to arginine by PCR site-directed
mutagenesis (see Materials and Methods). pLS104-Shk1DN
clones were transformed into L40 with pGAD-Byr2-CBD
or pGAD-Byr1EBB-1 and pLBD-Byr2. pLS104, pLS104-
Shk1K415,416RDN, pGAD, and pLBD-Lamin were tested as
FIG. 4. Comparison of two-hybrid binding characters of Byr2wt, Byr2P209S, and Byr2FBC-1. L40 was transformed with either pGAD-Ste4, pGAD-Ras1, pGAD-
Byr2-Reg, pGAD-Byr2-CBD, or pGAD and either pLBD-Byr2wt, pLBD-Byr2P209S, pLBD-Byr2FBC-1, or pLBD-Lamin. Transformants were tested for their ability to
grow on the media lacking histidine and assayed for b-galactosidase expression. Values shown are relative levels (means 6 standard deviations). DO-LT and DO-LTH
are DO-Leu-Trp and DO-Leu-Trp-His, respectively.
FIG. 5. Two-hybrid interaction with Byr1EBB-1. L40 was transformed with either pGAD-Byr1 or pGAD-Byr1EBB-1 and either pLBD-Byr2-Cat, pLBD-Lamin,
pLBD-Byr2wt, or pLBD-Byr2P209S. Transformants were tested for their ability to grow on the media lacking histidine and assayed for b-galactosidase expression. DO-LT
and DO-LTH are DO-Leu-Trp and DO-Leu-Trp-His, respectively.
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negative controls. Cells were plated on DO-Leu-Trp-Ade, and
transformants were tested for transactivation of HIS3 and lacZ
reporter genes. As shown in Fig. 7, Shk1DN was able to spe-
cifically induce the interaction between GAD-Byr2-CBD or
GAD-Byr1EBB-1 and LBD-Byr2, while the kinase-defective
Shk1K415,416RDN was unable to do so. Only one Shk1DN clone
failed to induce the interaction, and this clone was shown by
DNA sequencing to have a premature stop codon. Thus, we
determined that Shk1DN can induce the two-hybrid interaction
between Byr2-CBD or GAD-Byr1EBB-1 and the kinase cata-
lytic domain of wild-type Byr2. Shk1DN presumably achieves
this by abolishing Byr2 intramolecular interaction, thus releas-
ing the Byr2 kinase catalytic domain.
To test if Shk1DN can enhance the interaction between
Byr1wt and Byr2-Cat, we overexpressed Shk1DN in L40 cells
that contain GAD-Byr1wt and LBD-Byr2-Cat. We used the
pair GAD-Byr1wt and LBD-Byr2-Cat since they have a weak
two-hybrid interaction and any enhancement would be readily
observed. The overexpression of Shk1DN was unable to en-
hance that weak two-hybrid interaction. Thus, it appears that
Shk1DN affects specifically Byr2 intramolecular interaction,
between Byr2-Reg and Byr2-Cat.
DISCUSSION
Previous studies showed that Byr2 acts downstream of both
Ste4 and Ras1 in the sexual differentiation pathway in S. pombe
(3, 38), and two-hybrid data indicated that all three can form a
complex (3). In this study, we used deletion analysis to define
the nonoverlapping Ras1 binding domain of Byr2 and the Ste4
binding domain. These conclusions were confirmed by point
mutation analysis. Moreover, we used the byr2 gene with mu-
tations in its Ste4 and Ras1 regulatory domains in high-copy-
number genetic suppression studies to show that Byr2 activity
is dependent upon each of these interactions. Thus, a Byr2
mutant that fails to bind Ste4 (Byr2FBS) is a poor suppressor in
cells lacking Ras1, but such a mutant is comparable to Byr2wt
as a suppressor in cells lacking Ste4. Similarly, a Byr2 mutant
FIG. 6. Effect of overexpression of Ste4 or Ras1 or the two together on the two-hybrid interaction between GAD-Byr2-CBD and LBD-Byr2wt. YCJ4 was
transformed with either pGAD-Byr2-CBD or pGAD, either pLBD-Byr2wt or pLBD-Byr2P209S, either pLS104-Ste4 or pLS104, and either pYCp405-Ras1 or pYCp405.
Transformants were tested for their ability to grow on the media lacking histidine and assayed for b-galactosidase expression. DO-LTAY is DO-Leu-Trp-Ade-Lys.
FIG. 7. Effect of overexpression of activated Shk1 on the two-hybrid interaction between GAD-Byr2-CBD or GAD-Byr1EBB-1 and LBD-Byr2wt. (A) L40 was
transformed with either pGAD-Byr2-CBD or pGAD, either pLBD-Byr2, pLBD-Byr2P209S, or pLBD-Lamin, and either pLS104-Shk1DN or pLS104-Shk1K415,416RDN
or just with the expression vector without an insert. Transformants were tested for their ability to grow on the media lacking histidine and assayed for b-galactosidase
expression. (B) L40 was transformed with either pGAD-Byr1EBB-1 or pGAD, either pLBD-Byr2wt, pLBD-Byr2P209S, or pLBD-Lamin, and pLS104-Shk1DN or just the
expression vector. Transformants were tested for their ability to grow on the media lacking histidine and assayed for b-galactosidase expression. DO-LTA and
DO-LTAH are DO-Leu-Trp-Ade and DO-Leu-Trp-Ade-His, respectively.
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that fails to bind Ras1 (Byr2FBR) is a poor suppressor in cells
lacking Ste4 but is comparable to Byr2wt in cells lacking Ras1.
Thus, not only does Byr2 act downstream of Ste4 and Ras1 and
not only does it also interact with these proteins, but it is also
dependent upon them. Furthermore, Byr2 can respond to ei-
ther Ste4 or Ras1 in the absence of the other.
An inhibitory role for the MEKK regulatory domain has
long been suspected since truncation or alteration of the N
terminus often yields constitutively active kinases (14, 36).
Physical interaction between the regulatory domains and ki-
nase catalytic domains, however, has not been reported for
RAF, MEKK, or STE11. Fortuitously, we observed a weak
two-hybrid interaction between the separated regulatory and
catalytic domains of Byr2. We mapped the catalytic binding
domain of Byr2 by both deletion and point mutation analyses
to a region which minimally overlapped with the Ras1 binding
domain. We have tried but failed to demonstrate this interac-
tion using purified protein from E. coli expression systems.
This failure to confirm interaction by biochemical studies
might be due to the weakness of the interaction. The two-
hybrid system is recognized as being a more sensitive indicator
of interaction than simple coprecipitation or affinity chroma-
tography. A weak interaction between the regulatory and cat-
alytic domains of Byr2 might be predicted because strong in-
tramolecular interactions would interfere with regulation.
Alternatively, bacterially produced proteins might not fold
properly or might lack a critical posttranslational modification.
Nevertheless, further genetic and two-hybrid studies strongly
suggest the physiological relevance of this interaction.
Point mutations that abolish interaction between the regu-
latory and catalytic domains activate Byr2. Byr2P209S, which
was previously shown to be an activated mutant of Byr2 (31), is
mutated in the regulatory region which we have defined as the
catalytic binding domain. While this in itself might have been
fortuitous, all four Byr2FBC mutants that we examined were
activated and behaved indistinguishably from Byr2P209S in our
genetic tests. These results provide confirmation of the two-
hybrid studies and strongly suggest that intramolecular binding
between the regulatory and catalytic domains is autoinhibitory.
If the hypothesis that intramolecular binding of regulatory
and catalytic domains occurs is correct, then we should be able
to observe the breaking of this interaction. Using two-hybrid
analysis, we compared Byr2wt and Byr2P209S for the ability to
interact with proteins that bind the catalytic domain. We used
three such proteins: the separate regulatory domain itself (Byr2-
Reg), the separate catalytic binding domain (Byr2-CBD), and
a mutant Byr1 that was selected for tighter binding to the Byr2
catalytic domain. All three proteins had much stronger inter-
action with Byr2P209S than with Byr2wt. We conclude that mu-
tants altered in the catalytic binding domain open up the con-
formation of Byr2 by breaking intramolecular binding.
Because mutants with alterations in the Byr2 regulatory do-
main can apparently activate the kinase and alter its confor-
mation, we suspected that other regulatory components of the
signaling pathway might perform this function physiologically.
Using the two-hybrid assay for the open configuration of Byr2,
we were able to test components of the system for their ability
to induce this conformational change. We failed to observe
opening of Byr2 by Ras1 or Ste4 or both. Failure to observe
opening with Ras1 or Ste4 may indicate that those proteins
have other functions (see below) or may merely reflect a tech-
nical obstacle. On the other hand, an activated form of Shk1
was extremely effective at opening Byr2.
Shk1 is one of the S. pombe homologs of S. cerevisiae STE20.
Like STE20, Shk1 is also implicated in the sexual differentia-
tion of S. pombe (33). A direct demonstration of the involve-
ment of the shk1 gene in the sexual differentiation of S. pombe
has not been straightforward, since disruption of Shk1 is lethal
(26, 33). Shk1 is associated with Cdc42, a member of the Rho
family of guanine nucleotide-binding proteins, which is impli-
cated in its activation and localization and is required for both
morphological and sexual differentiation (6, 26, 33, 34). Cdc42,
in turn, is associated with Ras1 through their mutual and
cooperative interaction with Cdc24 (6), a guanine nucleotide
exchange protein (43).
We can assemble a consistent model for the activation of
Byr2 that incorporates our findings (Fig. 8). This model is
neither complete nor necessarily correct. In the depicted
model, Byr2 recognizes GTP-bound Ras1, associated with the
membrane. In this cellular region and through its association
with Ras1, Byr2 may encounter other components necessary
for its activation, including Shk1. We have depicted a further
association between Ras1 and Shk1, as discussed above. Upon
encountering an activated form of Shk1, Byr2 assumes an open
configuration. In the presence of Ste4, which is a leucine zipper
protein capable of homodimerization, the open configuration
of Byr2 might dimerize, leading to autophosphorylation and
further activation of Byr2.
This model does not depict the influence of the sex phero-
mone pathway upstream of Byr2. In principle, the pheromone
pathway could interact with any of the depicted components or
with yet another component. Shk1 is a leading candidate for
the site of this influence, because mutants that open the Byr2
configuration are best able to suppress the loss of Gpa1, the a
subunit of the heterotrimer thought to report sex pheromone
receptor occupancy. Moreover, STE20, the S. cerevisiae ho-
molog of Shk1, has been reported to function closely down-
stream of the bg subunit of the heterotrimer, which mediates
receptor occupancy in that organism (1, 24). Furthermore,
several mammalian PAK homologs have been shown to func-
tion downstream of heterotrimeric G-proteins (21).
Many aspects of this model can and should be challenged.
First, we have not demonstrated that Shk1 phosphorylates
Byr2, nor have we demonstrated autophosphorylation or the
subsequent activation of the kinase. It is not clear that Ras1
and/or Ste4 do not directly participate in opening the config-
uration of Byr2. We may have merely failed to observe such an
involvement. The role of Ste4 is very unclear. Dimerization
FIG. 8. Model for Byr2 activation. See Discussion.
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and autocatalytic activation by transphosphorylation are at-
tractive possibilities, with precedent in the tyrosine kinase fam-
ily. Furthermore, the protein kinase RAF can be activated by
dimerization (12). In support of this idea, we have generated
dimerizable Byr2 fusion proteins by attaching the leucine zip-
per domain of Ste4 and c-Jun (23) to Byr2 and have found that
they behave much like the activated Byr2FBC mutants (unpub-
lished data). However, we have never observed Ste4 induction
of the dimerization of Byr2 in the two-hybrid system, nor does
the dimerization model explain the need for the domain of
Ste4 that is homologous to S. cerevisiae STE50. An alternative
hypothesis is that the STE50-like domain of Ste4 brings an-
other protein to the Byr2 complex. Finally, the temporal se-
quence of events, if important, is still unclear. Further research
is clearly needed to confirm, extend, or correct this model.
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